Pallas Capital Advisors LLC Ironwood Pharmaceuticals Inc Transaction History
Pallas Capital Advisors LLC
- $2.24 Billion
- Q1 2025
A detailed history of Pallas Capital Advisors LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 14,340 shares of IRWD stock, worth $13,336. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,340Holding current value
$13,336% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IRWD
# of Institutions
231Shares Held
152MCall Options Held
11.5MPut Options Held
12.9K-
Black Rock Inc. New York, NY22.9MShares$21.3 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$15.2 Million22.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.7MShares$14.6 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY9.47MShares$8.81 Million0.59% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.07MShares$8.43 Million0.06% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $143M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...